CG
CODX

Cutler Group’s Co-Diagnostics CODX Stock Holding History

Cutler Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed – – 3909
2022
Q4 		$0 Sell
5
-288
-98% -$27K ﹤0.01% 4492
2022
Q3 		$28K Sell
293
-34
-10% -$4.75K ﹤0.01% 2345
2022
Q2 		$54K Buy
327
+282
+627% +$42.9K ﹤0.01% 1893
2022
Q1 		$8K Buy
45
+40
+800% +$8.28K ﹤0.01% 3754
2021
Q4 		$1K Sell
5
-29
-85% -$7.61K ﹤0.01% 4949
2021
Q3 		$9K Buy
34
+4
+13% +$1.17K ﹤0.01% 3990
2021
Q2 		$7K Sell
30
-8
-21% -$2.06K ﹤0.01% 4167
2021
Q1 		$10K Sell
38
-15
-28% -$5.99K ﹤0.01% 3791
2020
Q4 		$14K Sell
53
-27
-34% -$10K ﹤0.01% 2928
2020
Q3 		$32K Sell
80
-139
-63% -$71.4K ﹤0.01% 2100
2020
Q2 		$127K Buy
219
+19
+10% +$8.67K 0.01% 1152
2020
Q1 		$45K Buy
+200
New +$34.7K ﹤0.01% 1782

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cutler Group's CODX Position: Q1 2023 in Review

Cutler Group sold out of Co-Diagnostics (CODX) in Q1 2023, closing a stake of 5 shares.

Cutler Group first reported a position in CODX in Q1 2020 and held it in 12 quarters. The position peaked at $127K in Q2 2020. 51 funds tracked by Wall St. Rank hold CODX as of Q1 2023.

  • Cutler Group reported no remaining Co-Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5 Co-Diagnostics shares in Q1 2023.
  • Cutler Group first reported a position in Co-Diagnostics in Q1 2020 and held it in 12 quarters.
  • Cutler Group's Co-Diagnostics position peaked at $127K in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.